Phase I Trial of MK-3475 and Concurrent Chemo/Radiation for the Elimination of Small Cell Lung Cancer
Phase of Trial: Phase I
Latest Information Update: 17 Nov 2017
At a glance
- Drugs Pembrolizumab (Primary) ; Carboplatin; Cisplatin; Etoposide
- Indications Small cell lung cancer
- Focus Adverse reactions
- 20 Feb 2017 Planned End Date changed from 1 Aug 2023 to 1 Jul 2023.
- 23 Jul 2015 Planned primary completion date changed from 1 Aug 2023 to 1 Jul 2023 as per ClinicalTrials.gov record.
- 23 Jul 2015 Status changed from not yet recruiting to recruiting as per ClinicalTrials.gov record.